Today: 20 June 2026

Stocks take a breather after oil spike, Nvidia in focus

Stocks take a breather after oil spike, Nvidia in focus

U.S. stocks fell Friday as rising oil prices and Treasury yields ended Wall Street’s AI-driven rally, with the S&P 500 dropping 1.24% and the Nasdaq down 1.54%. The S&P 500 still posted a 0.1% weekly gain, but the Russell 2000 slid 2.4%. April consumer prices rose 0.6%, the largest annual gain since May 2023. Investors now see a 60% chance of a Fed rate hike by January.
16 May 2026
·····
Nvidia, Walmart, and Big Utility Deal Set for Monday Trading

Nvidia, Walmart, and Big Utility Deal Set for Monday Trading

NextEra Energy and Dominion Energy are in merger talks on a stock deal that could create a $400 billion utility, Reuters reported, citing the Financial Times. U.S. stocks fell over 1% Friday as oil prices and Treasury yields climbed. Nvidia reports earnings Wednesday after a 36% rally since March. Kalshi and Polymarket data show little expectation of a June Fed rate move.
16 May 2026
·······
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 16.05.2026

LIVEMarkets rolling coverageStarted: May 16, 2026, 4:00 AM EDTUpdated: May 17, 2026, 3:59 AM EDT Treasurer Jim Chalmers Defends Budget's Impact on Young Investors Amid Tax Changes May 17, 2026, 3:58 AM EDT. Treasurer Jim Chalmers defended the federal budget’s tax changes targeting Capital Gains Tax (CGT) and negative gearing, measures aimed at addressing intergenerational inequality. The government plans to reduce the CGT discount and restrict negative gearing to new home purchases, affecting young investors who use the share market and rentvesting-a strategy of renting while owning property elsewhere-to save for housing deposits. Critics say these changes limit key wealth-building
16 May 2026
·
Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

Dow Drops 537 Points With After-Hours Selling Threatening Wall Street AI Rally

U.S. stock ETFs fell in after-hours trading Friday following a more than 1% drop in the S&P 500, Dow, and Nasdaq. Oil surged 4.2% to $105.42 a barrel and the 10-year Treasury yield hit 4.597%, fueling concerns over inflation and Fed rate hikes. Nvidia, AMD, and Intel led chip declines, while Berkshire Hathaway disclosed a $2.65 billion Delta stake and exited Amazon, Visa, and Mastercard.
16 May 2026
·······
Accuray inks 10-year cancer tech agreement, shares in focus

Accuray inks 10-year cancer tech agreement, shares in focus

Accuray and the University of Wisconsin School of Medicine and Public Health signed a 10-year research agreement focused on Accuray’s Stellar adaptive radiotherapy platform. The announcement came after market close, with Accuray shares ending down 5.2% at $0.27. The deal follows Accuray’s recent withdrawal of fiscal 2026 guidance and ongoing financial pressures.
16 May 2026
·
Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials Gains as Filing Signals $3.54 Liquidation Payout Possible

Origin Materials asked shareholders to approve a plan to liquidate and dissolve the company, estimating an initial payout of $0.61 to $3.54 per share depending on asset sales and claims. Shares rose 15% to $1.43 after the filing. The company reported a 91% drop in first-quarter revenue and warned it may not survive without the wind-down. Origin cut 59% of its workforce and CEO John Bissell stepped down May 1.
16 May 2026
·
NextNRG Q1 Revenue Up, Cash Warning Still in Place

NextNRG Q1 Revenue Up, Cash Warning Still in Place

NextNRG reported first-quarter revenue of $21.1 million, up 29% from a year earlier, but its net loss widened to $10.8 million. Cash fell to $208,048 at quarter-end, and management warned it needs immediate capital to continue operations. Shares closed at $0.2804 on Nasdaq, down nearly 6%. Total liabilities reached $34.3 million, with a stockholders’ deficit of $22 million.
16 May 2026
··
HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics jumps 262% after Trimmune deal, Q1 profit, Nasdaq risk update

HCW Biologics shares jumped 262% to $1.22 Friday after the company posted a $3.47 million first-quarter profit, driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. The company faces a possible Nasdaq delisting and will ask shareholders to approve a reverse stock split on June 15. HCW plans to report early Phase 1 data for its alopecia drug in the first half of 2026.
16 May 2026
·
BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

BofA 7-Eleven ATM Settlement Opens, Deadline June 29 for Former Clients

Bank of America agreed to pay $2.25 million to settle claims it charged duplicate balance-inquiry fees at FCTI-owned ATMs in 7-Eleven stores. Former account holders must file claims by June 29; current customers will receive automatic credits if the court approves the deal. Final approval is set for Aug. 21 in San Diego federal court. The class period covers May 2018 to November 2021.
16 May 2026
·
SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX Nasdaq Listing Draws Closer as IPO Timeline Accelerates

SpaceX plans to list on Nasdaq as early as June 12 under the ticker SPCX, seeking to raise about $75 billion at a $1.75 trillion valuation, sources told Reuters. The company aims to publish its prospectus next week, with investor meetings set for June 4. Bloomberg reported Brookfield has already placed a $2 billion bet ahead of the IPO. SpaceX’s filing includes supervoting shares and strict limits on shareholder proposals.
16 May 2026
····
Broadcom Slips as AI Chip Stocks See Selling

Broadcom Slips as AI Chip Stocks See Selling

Broadcom shares fell 3.3% to $425.19 on Friday, leading a sector-wide drop in AI-linked chip stocks after a recent rally. No company-specific news triggered the decline. Higher oil prices and Treasury yields fueled inflation concerns, raising expectations that the Federal Reserve could keep interest rates elevated. Nvidia and AMD also posted sharp losses.
16 May 2026
·
Alphabet Falls as Ackman Exits, Broader Tech Weakness

Alphabet Falls as Ackman Exits, Broader Tech Weakness

Alphabet shares fell 1.1% Friday after Bill Ackman’s Pershing Square disclosed it sold its entire Alphabet stake to fund a new Microsoft position. The Nasdaq dropped 1.54% as rising oil prices and Treasury yields pressured tech stocks. Microsoft rose 3.1% on the news. Alphabet reported Q1 revenue up 22% to $109.9 billion, but raised 2026 capex guidance to as much as $190 billion.
16 May 2026
··
Macy’s gains after Berkshire Hathaway purchase; tariff worries persist

Macy’s gains after Berkshire Hathaway purchase; tariff worries persist

Berkshire Hathaway disclosed a $55 million stake in Macy’s, sending the retailer’s shares up 5.9% in after-hours trading. The position, revealed in a quarterly SEC filing, covers about 3.04 million shares as of March 31. Macy’s board declared a quarterly dividend of 19.15 cents per share, payable July 1. The company forecast lower net sales for fiscal 2026 amid ongoing tariff and consumer spending pressures.
16 May 2026
·
Berkshire Puts $2.65 Billion Into Delta Air Lines Shares

Berkshire Puts $2.65 Billion Into Delta Air Lines Shares

Berkshire Hathaway disclosed a $2.65 billion stake in Delta Air Lines, marking its return to the carrier after exiting airline stocks in 2020. The holding totaled 39.8 million shares as of March 31, according to a regulatory filing. Delta shares rose 3.2% after the news. The investment comes as Delta faces higher fuel costs and reduced near-term growth plans.
16 May 2026
··
Devon Energy Shares Climb After $8 Billion Buyback

Devon Energy Shares Climb After $8 Billion Buyback

Devon Energy shares closed up 4.76% at $49.49 Friday after oil prices rallied, with Brent settling at $109.26 and WTI at $105.42 amid Strait of Hormuz concerns. The move follows Devon’s completion of its Coterra merger and approval of an $8 billion share buyback. Trading volume reached about 16.5 million shares. Devon’s stock remains below its 52-week high of $52.71.
16 May 2026
····
UnitedHealth Stock Watches Berkshire Exit, Optum AI Effort

UnitedHealth Stock Watches Berkshire Exit, Optum AI Effort

Berkshire Hathaway sold its entire UnitedHealth Group stake in the first quarter, less than a year after buying 5.04 million shares. UnitedHealth shares closed at $393.85 Friday, down 1.3%. Bloomberg reported UnitedHealth is tracking some Optum workers’ use of AI tools as it expands technology in operations. Analysts say insurers need another quarter of clean medical-cost data before judging recovery.
16 May 2026
··
Gold Drops on Dollar Gains, Wall Street Sinks as Yields Jump

Gold Drops on Dollar Gains, Wall Street Sinks as Yields Jump

The dollar rose for a fifth day Friday, pushing gold to a one-week low and sending the euro to $1.1623, its weakest in five weeks. U.S. crude jumped 4.2% to $105.42 a barrel amid concerns over the Strait of Hormuz. The 10-year Treasury yield hit an 11.75-month high at 4.58%, while the Nasdaq ended a six-week winning streak. Silver plunged 7.7% to $77.07 an ounce.
16 May 2026
·
TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities Filing Throws Spotlight on GCT Semiconductor (GCTS), Raises Flags About 5G Chip Scale-Up and Liquidity

TD Securities (USA) LLC disclosed a 4.6% beneficial ownership in GCT Semiconductor Holding, Inc., mostly via warrants exercisable at $11.50 a share, far above Friday’s $1.83 stock price. GCT reported first-quarter revenue of $1.92 million and a net loss of $9.86 million, with 5G chipset deliveries rising 58% to 3,000 units.
15 May 2026
··
Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharma Stock Gains After Antibody News, 2027 Lyme Trial Planned

Tonix Pharmaceuticals filed new Phase 1 modeling data showing its experimental Lyme disease antibody, TNX-4800, could maintain serum levels above a proposed protective threshold for six months with a two-dose regimen. Shares rose $1.65 to $15.74 Friday. The company plans a Phase 2 trial in 2027, pending FDA agreement. No Lyme vaccine is currently available in the U.S.
15 May 2026
···
1 … 143 144 145 146 147 … 2,086

Stock Market Today

  • Teledyne Technologies Stock Seen 15.9% Undervalued After Q1 Earnings Beat
    June 19, 2026, 10:51 PM EDT. Teledyne Technologies (TDY) shares trade at $619.58, about 15.9% below the fair value estimate of $736.85 despite a strong Q1 2026 earnings beat and new defense product launches. The company benefits from robust global defense spending, especially in unmanned systems, supporting revenue growth and margin gains. However, challenges such as softer organic sales and margin pressure in acquired units pose risks. TDY's price-to-earnings ratio stands at 30.8x, higher than the fair value ratio of 25.9x but below the industry average of 32.9x, indicating mixed signals for valuation and investor risk.

Latest articles

JBS shutdowns put pressure on U.S. beef as cattle prices rise

JBS shutdowns put pressure on U.S. beef as cattle prices rise

20 June 2026
JBS USA will close its Souderton, PA, and Memphis, TN, meat plants on August 14, cutting 1,693 jobs as tight cattle supplies drive negative U.S. beef margins; USDA data show beef prices up 14.8% year-over-year and forecast to rise another 12.1% in 2026, signaling ongoing cost pressure for packers and consumers.
TSMC Leads Nvidia in Short Week Chip Gains

TSMC Leads Nvidia in Short Week Chip Gains

20 June 2026
TSMC’s U.S.-listed shares soared 6.9% to $462.12, outpacing Nvidia’s 3.0% gain, as investors favored broad chip manufacturing exposure after an interim U.S.-Iran deal eased inflation fears and Taiwan’s central bank raised its 2026 economic-growth forecast to 9.45% on AI-driven semiconductor demand.
Intel Beats AMD for Week After Trump Comments on Apple Chips

Intel Beats AMD for Week After Trump Comments on Apple Chips

20 June 2026
Intel soared 10.6% to a record $133.99 after President Trump said Apple agreed to work with Intel on U.S. chip design and production, though neither company confirmed terms or details; analysts are split on the deal’s value, with Intel’s gains outpacing AMD’s 4.9% rise as the chip sector hit a record close.
Go toTop